Can patients with good tumor regression grading after neoadjuvant chemoradiotherapy be exempted from lateral lymph node dissection?

HIGHLIGHTS

• who: Xianwei Liu from the China Department of General Surgery, Jiujiang , Peopleu2019s Hospital, Jiujiang, Jiangxi, Department have published the paper: Can patients with good tumor regression grading after neoadjuvant chemoradiotherapy be exempted from lateral lymph node dissection?, in the Journal: (JOURNAL)
• how: The authors hypothesized that the regression of LLN was also correlated with pTRG and mrTRG in advanced rectal cancer patients after nCRT which was worthy of further investigation. The authors chose this system to evaluate the mrTRG of the patients . Although the authors did not assess lateral LRG the results showed that the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.